Startup Valuation Methods: How VCs Actually Price Your Company

Startup valuation is one of the most misunderstood aspects of fundraising. Founders often expect valuation to follow a formula — apply a revenue multiple, discount future cash flows, arrive at a number. In practice, early-stage startup valuation is far more subjective than that, driven by market comparables, investor conviction, and negotiation.

Understanding how investors actually think about valuation — and which methods apply at which stages — gives founders better footing in the negotiation. This guide covers the five primary valuation methods, the benchmarks by stage, and how to approach the negotiation effectively.

Why Traditional Valuation Methods Don't Apply Early-Stage

The standard corporate finance valuation tools — discounted cash flow (DCF) analysis, earnings multiples (P/E), and book value — require historical financial performance and reasonable financial predictability. Most early-stage startups have neither.

A company with six months of revenue and no clear path to profitability cannot be reliably valued using a DCF model because the terminal value assumptions dominate the calculation and are essentially arbitrary. Applying a P/E multiple to a company with negative earnings produces a nonsensical result. The traditional tools are not wrong — they are simply inapplicable to companies where the future is radically uncertain.

Early-stage investors instead use frameworks that acknowledge this uncertainty while still arriving at a number that can anchor the negotiation.

Method 1: The Berkus Method (Pre-Revenue)

The Berkus Method, developed by angel investor Dave Berkus, assigns a dollar value to five qualitative dimensions of a startup's potential:

The maximum pre-money valuation under the Berkus Method is $2.5 million. In markets where deal sizes have inflated (particularly Silicon Valley), some practitioners have updated the maximum value per element to $1 million, producing a maximum of $5 million.

The Berkus Method is most useful at the pre-seed stage for companies with no revenue and as a structured way to think about risk reduction rather than as a precise calculation.

Method 2: The Scorecard Method

The Scorecard Method, developed by Bill Payne, compares the target company to the average pre-money valuation of funded companies in the same region and stage, then adjusts based on weighted factor comparisons.

A typical scorecard for a pre-seed SaaS company in the U.S.:

If the average pre-money valuation for comparable companies in your region and stage is $4.5 million, the Scorecard Method produces a valuation of $4.5M × 1.09 = $4.9 million.

The Scorecard Method is most useful when reliable comparables are available. In markets with active angel investment communities, regional data on pre-money valuations is sometimes available through angel network databases.

Method 3: Revenue Multiples (Post-Revenue, Seed to Series A)

Once a company has meaningful recurring revenue, investors shift to revenue multiples: a valuation calculated as a multiple of annual recurring revenue (ARR) or trailing twelve months (TTM) revenue.

Pre-money valuation = ARR × revenue multiple

Revenue multiples vary significantly by sector, growth rate, gross margin, and market conditions. In 2026, typical revenue multiples:

Example: A company with $2.5 million ARR growing at 80% year-over-year with 72% gross margins might receive a 12-15x revenue multiple, producing a pre-money valuation of $30-37.5 million at the Series A.

These multiples contracted significantly from the peak of 2021-2022, when companies with strong growth commanded 20-30x ARR multiples. In 2026, multiples are normalized closer to historical averages, which penalizes high-growth but capital-inefficient companies relative to the 2021 peak.

Method 4: Comparable Transactions

The comparables method looks at what investors paid for similar companies in recent transactions. This is standard in M&A and later-stage VC but is also used at seed and Series A to provide a market anchor.

Sources for comparable transaction data: Crunchbase, Pitchbook, CB Insights, and aggregated industry reports that track valuation multiples by sector and stage.

The challenge with comparables for early-stage startups is that transaction terms are often not disclosed, and the characteristics of the comparable company (growth rate, gross margin, customer concentration, market size) may differ materially from the target company.

Method 5: VC Return Math (Venture Method)

Some investors calculate valuation by working backward from the return they need to achieve their fund's target IRR. The logic:

1. What does this company need to be worth in five to seven years to generate a 10x return? (The target exit value)
2. What multiple does that imply on my investment today? (The target return multiple)
3. Working backward: what pre-money valuation allows me to own enough of the company to generate that return, accounting for future dilution?

Example: An investor needs a 10x return on a $1.5 million check. They believe the company could exit at $150 million in five years. They need to own at least 10% at exit ($15M / $150M). Accounting for two more rounds of 20% dilution each: they need to own 10% / (1-0.2) / (1-0.2) = 15.6% today. At a $1.5 million investment: post-money valuation = $1.5M / 15.6% = $9.6 million post-money, or $8.1 million pre-money.

This method reveals why fund size matters for valuation negotiations. A $500 million fund writing a $1.5 million check needs a 10x return = $15 million from this investment. At a $9.6 million post-money valuation (15.6% ownership), a $150 million exit produces exactly $23.4 million — a 15.6x return on this check, but immaterial to the fund's overall return. The fund will not spend much partner time on this company. An investor with a smaller fund ($50 million) and the same check size will have very different incentives and will prioritize this company much more highly.

Negotiating Valuation

Set a range, not a fixed number. Anchoring with a range ("we are thinking about this round as valuing the company between $8-12 million pre-money") preserves negotiating room without revealing your reserve price.

Justify with comparables. Be prepared to name two to three recent comparable transactions and explain why your company merits a similar or better multiple. Investors who disagree will do so with their own comparables, which gives you real market information about where the deal can close.

Optimize for the right investor at a reasonable valuation. The difference between a $7 million and a $9 million pre-money valuation at seed is approximately 2% in founder dilution at a $1.5 million raise. That is meaningful but not as meaningful as getting the right investor who will add the most value in the next 24 months. Over-optimizing for valuation at the expense of investor quality is a common and expensive mistake.

Understand the option pool shuffle. When an investor proposes a pre-money valuation, check whether the proposed option pool expansion is included in the pre-money or post-money valuation. If a $10 million pre-money valuation includes a 15% option pool expansion, the effective pre-money valuation (before the option pool) is approximately $8.5 million — a material difference in actual founder dilution.

Valuation negotiation is one dimension of a complex term sheet. Work with a startup attorney who has closed multiple venture rounds to ensure you understand all the economic and governance implications before signing.